Susquehanna International Group
ICVX

Susquehanna International Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Susquehanna International Group’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,200
Closed -$126K – 13576
2023
Q3 		$126K Sell
16,200
-24,300
-60% -$201K ﹤0.01% 10728
2023
Q2 		$402K Buy
+40,500
New +$324K ﹤0.01% 8820
2023
Q1 		– Sell
-23,000
Closed -$183K – 13814
2022
Q4 		$183K Buy
+23,000
New +$98.7K ﹤0.01% 10262
2022
Q3 		– Sell
-14,100
Closed -$81K – 14397
2022
Q2 		$81K Buy
+14,100
New +$110K ﹤0.01% 11653

Susquehanna International Group's ICVX Position: Q1 2024 in Review

Susquehanna International Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 13,981 shares — an estimated $220K sold.

Susquehanna International Group first reported a position in ICVX in Q1 2023 and held it in 3 quarters. The position peaked at $485K in Q1 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Susquehanna International Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 13,981 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $220K.
  • Susquehanna International Group first reported a position in Icosavax, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Susquehanna International Group's Icosavax, Inc. Common Stock position peaked at $485K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.